Please login to the form below

Mvasi

This page shows the latest Mvasi news and features for those working in and with pharma, biotech and healthcare.

Roche faces biosimilar blitz in 2018

year. Avastin (bevacizumab), Roche’s biggest-selling cancer drug, will imminently face some stiff competition in the EU from Amgen and Allergan’s recently licenced biosimilar Mvasi - which became the first

Latest news

Amgen and Allergan win first EU approval for Avastin biosimilar

Amgen and Allergan win first EU approval for Avastin biosimilar. Mvasi, their version of Roche's blockbuster, is licensed for six types of cancers. ... The approval was based on data showing Mvasi and beveacizumab are highly similar, with no clinically
Mylan gets first biosimilar Herceptin OK from FDA

cancer antibody after Amgen and Allergan got a green light for their Mvasi biosimilar of Roche’s Avastin (bevacizumab) in September.
Amgen's Mvasi is first FDA-approved cancer biosimilar

Amgen's Mvasi is first FDA-approved cancer biosimilar. Offers prospect of lower-cost alternative to Roche's Avastin. ... Mvasi reaches the market ahead of rival Avastin biosimilars from Boehringer Ingelheim, Samsung Bioepis, Pfizer and Biocon/Mylan that

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Director – Medical Education – Oxford: Negotiable

Medical Writer - (London, Brighton or Copenhagen): Competitive

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Medical Writer: Great salary and benefits

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior Account Manager or AD - Medical Communications: Salary TBC

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Editor – Medical Education Agency – Bucks: Salary TBC

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Medical Writer: Great salary and bebefits

Senior Programme Executive: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Scientific Director: Great salary and bebefits

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Account Manager – Med Comms – London: Salary TBC

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Account Manager / Account Director: Great salary and bebefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Subscribe to our email news alerts

PMHub

Add my company

CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...